Wiig Johan N, Larsen Stein G, Dueland Svein, Giercksky Karl-Erik
Department of Surgical Oncology, The Norwegian Radium Hospital, Oslo, Norway.
J Surg Oncol. 2005 Oct 1;92(1):70-5. doi: 10.1002/jso.20340.
The importance of pT0 stage after preoperative radiation/chemoradiation is unclear.
Four hundred and nineteen patients had preoperative irradiation (46-50 Gy/2 Gy fractions) for primary locally advanced (PLA) or locally recurrent (LR) rectal cancer. 141 PLA and 65 LR cases with R0 resections/M0 stage are studied. Two of the pT0 PLA patients had also been given sensitizing chemotherapy and two pT0 in the LR group had received pelvic hyperthermia as well.
pT0 was achieved in 7% of 229 PLA and 8% of 190 LR patients. For the PLA group, actuarial 5-year survival of pT0 was 90% versus 53% for the pT > 0 group. The difference was statistically significant. At five years local recurrence was zero in pT0 patients versus 23% in pT > 0 (not significant). For the LR groups 5-year-survival was 62% for pT0 versus 45% for the other pT-stages, local recurrence was 17 and 35% respectively (not significant). The seemingly better results for pT0 cases of PLA cancers versus the LR ones did not reach statistical significance.
pT0 after preoperative irradiation is associated with improved survival for pT0 cases of PLA. Our studies on pT0 LR was suggestive of an improvement in this group as well.
术前放疗/放化疗后pT0期的重要性尚不清楚。
419例原发性局部进展期(PLA)或局部复发性(LR)直肠癌患者接受了术前照射(46 - 50 Gy,每次2 Gy)。对141例PLA和65例R0切除/M0期的LR病例进行了研究。2例pT0期PLA患者还接受了增敏化疗,LR组2例pT0期患者还接受了盆腔热疗。
229例PLA患者中有7%达到pT0期,190例LR患者中有8%达到pT0期。对于PLA组,pT0期患者的5年精算生存率为90%,而pT>0组为53%。差异具有统计学意义。5年时,pT0期患者局部复发率为零,而pT>0组为23%(无统计学意义)。对于LR组,pT0期患者的5年生存率为62%,其他pT分期患者为45%,局部复发率分别为17%和35%(无统计学意义)。PLA癌pT0期病例与LR病例相比,看似更好的结果未达到统计学意义。
术前放疗后pT0期与PLA的pT0期病例生存率提高相关。我们对pT0期LR的研究也提示该组患者生存率有所提高。